This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reason, D. C.
Right arrow Articles by Lucas, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reason, D. C.
Right arrow Articles by Lucas, A. H.

 Previous Article  |  Next Article 

Infection and Immunity, February 1999, p. 994-997, Vol. 67, No. 2
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Polysaccharide Binding Potential of the Human A2 or A18 Kappa Light Chain Homologues

Donald C. Reason,* T. Charis Wagner,dagger Vanessa R. Tang, Karen D. Moulton, and Alexander H. Lucas

Children's Hospital Oakland Research Institute, Oakland, California

Received 7 July 1998/Returned for modification 17 September 1998/Accepted 30 October 1998

Antibodies having light (L) chains encoded by the kappa II-A2 variable region gene segment predominate in the human response to the Haemophilus influenzae type b polysaccharide (Hib PS). To determine whether the closely related homologue of the A2 gene, the kappa II-A18 gene, has the potential to contribute to the repertoire, we examined Hib PS binding to a series of recombinant Fab fragments having either A2 or A18 L chains isolated from a Hib PS-vaccinated adult. The ability to bind Hib PS resided exclusively with those Fab fragments having A2 and containing an insertional arginine at the variable-joining junction. Thus, despite the sequence similarity between A2 and A18, only A2 contributes to the canonical Hib PS paratope.


* Corresponding author. Mailing address: Children's Hospital Oakland Research Institute, 747 52nd St., Oakland, CA 94609. Phone: (510) 428-3212. Fax: (510) 428-3608. E-mail: dreason{at}paratope.com.

dagger Present address: Berlex Laboratories, Inc., Richmond, Calif.


Infection and Immunity, February 1999, p. 994-997, Vol. 67, No. 2
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.